IDEAS home Printed from https://ideas.repec.org/p/wbk/wbrwps/10067.html
   My bibliography  Save this paper

Financing Vaccine Equity : Funding for Day-Zero of the Next Pandemic

Author

Listed:
  • Agarwal,Ruchir
  • Reed,Tristan

Abstract

A lack of timely financing for purchases of vaccines and other health products impeded theglobal response to the COVID-19 pandemic. Based on analysis of contract signature and delivery dates in COVID-19 vaccineadvance purchase agreements, this paper finds that 60–75 percent of the delay in vaccine deliveries to low- andmiddle-income countries is attributable to their signing purchase agreements later than high-income countries, whichplaced them further behind in the delivery line. A pandemic Advance Commitment Facility with access to a credit line onday-zero of the next pandemic could allow low- and middle-income countries to secure orders earlier, ensuring amuch faster and equitable global response than during COVD-19. The paper outlines four options for a financier toabsorb some or all of the risk associated with the credit line and discusses how the credit would complement otherproposals to strengthen the financing architecture for pandemic preparedness, prevention, and response.

Suggested Citation

  • Agarwal,Ruchir & Reed,Tristan, 2022. "Financing Vaccine Equity : Funding for Day-Zero of the Next Pandemic," Policy Research Working Paper Series 10067, The World Bank.
    • Handle: RePEc:wbk:wbrwps:10067
    as

    Download full text from publisher

    File URL: http://documents.worldbank.org/curated/en/099500105262228687/pdf/IDU0cdc5294e039a8045fb0aa670908d56a28371.pdf
    Download Restriction: no
    ---><---

    Other versions of this item:

    References listed on IDEAS

    as
    1. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
    2. Michael Kremer & Jonathan Levin & Christopher M. Snyder, 2022. "Designing Advance Market Commitments for New Vaccines," Management Science, INFORMS, vol. 68(7), pages 4786-4814, July.
    3. Ruchir Agarwal & Ms. Gita Gopinath & Jeremy Farrar & Richard Hatchett & Peter Sands, 2022. "A Global Strategy to Manage the Long-Term Risks of COVID-19," IMF Working Papers 2022/068, International Monetary Fund.
    4. Agarwal,Ruchir & Reed,Tristan, 2021. "How to End the COVID-19 Pandemic by March 2022," Policy Research Working Paper Series 9632, The World Bank.
    5. Demombynes,Gabriel, 2020. "COVID-19 Age-Mortality Curves Are Flatter in Developing Countries," Policy Research Working Paper Series 9313, The World Bank.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Susan Athey & Juan Camilo Castillo & Esha Chaudhuri & Michael Kremer & Alexandre Simoes Gomes & Christopher M Snyder, 2022. "Expanding capacity for vaccines against Covid-19 and future pandemics: a review of economic issues," Oxford Review of Economic Policy, Oxford University Press and Oxford Review of Economic Policy Limited, vol. 38(4), pages 742-770.
    2. Scott Duke Kominers & Alex Tabarrok, 2022. "Vaccines and the Covid-19 pandemic: lessons from failure and success," Oxford Review of Economic Policy, Oxford University Press and Oxford Review of Economic Policy Limited, vol. 38(4), pages 719-741.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Daniel P. Gross & Bhaven N. Sampat, 2022. "Crisis Innovation Policy from World War II to COVID-19," Entrepreneurship and Innovation Policy and the Economy, University of Chicago Press, vol. 1(1), pages 135-181.
    2. Dewatripont, Mathias, 2022. "Which policies for vaccine innovation and delivery in Europe?," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    3. Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
    4. Mihaela ZAMFIR & Ileana CIOBANU & Mihai Viorel ZAMFIR, 2021. "Vatra Luminoasa, age friendly study of intergenerational architecture in a Bucharest neighborhood," Smart Cities International Conference (SCIC) Proceedings, Smart-EDU Hub, Faculty of Public Administration, National University of Political Studies & Public Administration, vol. 9, pages 437-460, November.
    5. Jacques Bughin & Francis Hinterman & Sybille Berjoan, 2022. "A Good Crisis (not) Wasted: How Exploiting and Expanding Dynamic Capabilities Shape Corporate Performance During the Covid Pandemic," Working Papers TIMES² WP2022-051, ULB -- Universite Libre de Bruxelles.
    6. Haas, Christian & Kempa, Karol & Moslener, Ulf, 2023. "Dealing with deep uncertainty in the energy transition: What we can learn from the electricity and transportation sectors," Energy Policy, Elsevier, vol. 179(C).
    7. Chad P. Bown & Thomas J. Bollyky, 2022. "How COVID‐19 vaccine supply chains emerged in the midst of a pandemic," The World Economy, Wiley Blackwell, vol. 45(2), pages 468-522, February.
    8. Batabyal, Amitrajeet & Beladi, Hamid, 2022. "City and Regional Demand for Vaccines Whose Supply Arises from Competition in a Bertrand Duopoly," MPRA Paper 113758, University Library of Munich, Germany, revised 28 Jun 2022.
    9. Lin Ma & Gil Shapira & Damien de Walque & Quy‐Toan Do & Jed Friedman & Andrei A. Levchenko, 2022. "The Intergenerational Mortality Trade‐Off Of Covid‐19 Lockdown Policies," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 63(3), pages 1427-1468, August.
    10. Enrico Berkes & Davide M. Coluccia & Gaia Dossi & Mara P. Squicciarini, 2023. "Dealing with adversity: Religiosity or science? Evidence from the great influenza pandemic," POID Working Papers 068, Centre for Economic Performance, LSE.
    11. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    12. Shapiro, Vladimir, 2021. "COVID-19 Sex-Age Mortality Modeling - A Use Case of Risk-Based Vaccine Prioritization," SocArXiv 5c8bd, Center for Open Science.
    13. Wang, Jian & Jiang, Wenjing & Wu, Xinpei & Yang, Mengdie & Shao, Wei, 2023. "Role of vaccine in fighting the variants of COVID-19," Chaos, Solitons & Fractals, Elsevier, vol. 168(C).
    14. Wang, Fan & Xu, Danni & Zhuo, Xiaopo & Zhang, Chao & Liu, Yaoqi, 2022. "Improving consumer welfare in vaccine market: Pricing, government subsidies and consumer awareness," Transportation Research Part E: Logistics and Transportation Review, Elsevier, vol. 167(C).
    15. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
    16. Ahlvik, Lassi & van den Bijgaart, Inge, 2024. "Screening green innovation through carbon pricing," Journal of Environmental Economics and Management, Elsevier, vol. 124(C).
    17. Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023. "Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak," Research Policy, Elsevier, vol. 52(1).
    18. Michael Kremer & Christopher M. Snyder & Jonathan Levin, 2023. "Authors' response to Unjournal evaluations of "Advance Market Commitments: Insights from Theory and Practice"," The Unjournal Evaluations 2023-25, The Unjournal.
    19. Zéphirin Nganmeni & Roland Pongou & Bertrand Tchantcho & Jean‐Baptiste Tondji, 2022. "Vaccine and inclusion," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 1101-1123, October.
      • Zéphirin Nganmeni & Roland Pongou & Bertrand Tchantcho & Jean-Baptiste Tondji, 2022. "Vaccine and Inclusion," Working Papers 2202E Classification-C62,, University of Ottawa, Department of Economics.
      • Zéphirin Nganmeni & Roland Pongou & Bertrand Tchantcho & Jean‐baptiste Tondji, 2022. "Vaccine and inclusion," Post-Print hal-04257703, HAL.
    20. Yupeng Li & Kul Prasad Kapri, 2021. "Impact of Economic Factors and Policy Interventions on the COVID-19 Pandemic," Sustainability, MDPI, vol. 13(22), pages 1-18, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wbk:wbrwps:10067. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Roula I. Yazigi (email available below). General contact details of provider: https://edirc.repec.org/data/dvewbus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.